The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
An International Survey of Health Care Services Available to Patients With Tourette Syndrome
Abstract
Objective: Tourette syndrome (TS) is a neuropsychiatric disorder that is highly associated with several comorbidities. Given the complex and multifaceted nature of TS, the condition is managed by a wide variety of practitioners in different disciplines. The goal of this study was to investigate health service delivery and care practices by clinicians who see TS patients across different geographic settings internationally. Methods: A comprehensive questionnaire was developed to assess clinical care resources for patients with TS and was sent to clinicians in Canada (CA), the United States (US), Europe (EU), and the United Kingdom (UK). Responses were compared quantitatively between geographic regions. Results: The majority of respondents, regardless of region, reported that fewer than 40% of their case-load are patients with tics. The accessibility of TS services varied among regions, as indicated by differences in wait times, telemedicine offerings, comorbidity management and the availability of behavioral therapies. First-line pharmacotherapy preferences varied among physicians in different geographical regions with CA respondents preferring alpha-2-adrenergic agonists and respondents from the UK and EU preferring dopamine receptor antagonists. Discussion: The results suggest that there is a scarcity of specialized TS clinics, potentially making access to services challenging, especially for patients newly diagnosed with TS. Differences in regional pharmacotherapeutic preferences are reflected in various published treatment guidelines in EU and North America. The lack of dedicated specialists and telemedicine availability, coupled with differences in comorbidity management, highlight the need for interprofessional care and holistic management to improve health care delivery to patients with TS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The ESSTS survey indicated that BT is fairly widely available now in the regions of ESSTS members (although more available for children than adults), but caution is warranted when interpreting these results since data primarily originated from specialist clinics.”
From European clinical guidelines for Tourette syndrome and other tic disorders—version 2.0. Part II: psychological interventions (2022) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Collaborative Care for Depression: A Cumulative Meta-analysis and Review of Longer-term Outcomes
Gilbody, S. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.21.2314 · Cited by 1,340
Behavior Therapy for Children With Tourette Disorder: A Randomized Controlled Trial
Piacentini, J., Woods, D. W., Scahill, L., Wilhelm, S., Peterson, A. L., Chang, S., Ginsburg, G. S., Deckersbach, T., Dziura, J., Levi-Pearl, S., et al. (2010) · JAMA · doi:10.1001/jama.2010.607 · Cited by 790
Pringsheim, T., Okun, M. S., Müller-Vahl, K., Martino, D., Jankovic, J., Cavanna, A. E., Woods, D. W., Robinson, M., Jarvie, E., Roessner, V., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000007466 · Cited by 565
the ESSTS Guidelines Group, Roessner, V., Plessen, K. J., Rothenberger, A., Ludolph, A. G., Rizzo, R., Skov, L., Strand, G., Stern, J. S., Termine, C., et al. (2011) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-011-0163-7 · Cited by 461
Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders
Murphy, T. K., Lewin, A. B., Storch, E. A., & Stock, S. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.09.015 · Cited by 276
Research works printed but not linked: 44
- Knight, 2012, Prevalence of tic disorders: a systematic review and meta-analysis, Pediatr Neurol., 47, 77, 10.1016/j.pediatrneurol.2012.05.002 · DOI · Paper page
- Scharf, 2015, Population prevalence of Tourette syndrome: a systematic review and meta-analysis, Mov Disord., 30, 221, 10.1002/mds.26089 · DOI · Paper page
- Pringsheim, 2009, Understanding disability in Tourette syndrome, Dev Med Child Neurol., 51, 468, 10.1111/j.1469-8749.2008.03168.x · DOI
- Wilhelm, 2012, Randomized trial of behavior therapy for adults with Tourette syndrome, Arch Gen Psychiatry., 69, 795, 10.1001/archgenpsychiatry.2011.1528 · DOI · Paper page
- Scahill, 2013, Current controversies on the role of behavior therapy in Tourette syndrome, Mov Disord., 28, 1179, 10.1002/mds.25488 · DOI · Paper page
- Sandor, 2003, Pharmacological management of tics in patients with TS, J Psychosom Res., 55, 41, 10.1016/S0022-3999(03)00060-6 · DOI
- Pringsheim, 2012, Canadian guidelines for the evidence-based treatment of tic disorders: pharmacotherapy, Can J Psychiatry., 57, 133, 10.1177/070674371205700302 · DOI · Paper page
- Eddy, 2011, Quality of life in young people with Tourette syndrome: a controlled study, J Neurol., 258, 291, 10.1007/s00415-010-5754-6 · DOI · Paper page
- Conelea, 2011, Exploring the impact of chronic tic disorders on youth: results from the Tourette Syndrome Impact Survey, Child Psychiatry Hum Dev., 42, 219, 10.1007/s10578-010-0211-4 · DOI · Paper page
- Elstner, 2001, Quality of Life (QOL) of patients with Gilles de la Tourette's syndrome, Acta Psychiatr Scand., 103, 52, 10.1111/j.1600-0447.2001.00147.x · doi:10.1111/j.1600-0447.2001.00147.x · Paper page
- Storch, 2007, Quality of life in youth with Tourette's syndrome and chronic tic disorder, J Clin Child Adolesc Psychol., 36, 217, 10.1080/15374410701279545 · DOI · Paper page
- Aldred, 2015, Tourette syndrome and socioeconomic status, Neurol Sci., 36, 1643, 10.1007/s10072-015-2223-0 · DOI
- Cavanna, 2013, Health-related quality of life in Gilles de la Tourette syndrome: a decade of research, Behav Neurol., 27, 83, 10.1155/2013/732038 · DOI
- Bitsko, 2014, A National Profile of Tourette Syndrome, 2011–2012, J Dev Behav Pediatr., 35, 317, 10.1097/DBP.0000000000000065 · DOI
- Bitsko, 2013, Health Care Needs of Children With Tourette Syndrome, J Child Neurol., 28, 1626, 10.1177/0883073812465121 · DOI
- Freeman, 2000, An international perspective on Tourette syndrome: selected findings from 3500 individuals in 22 countries, Dev Med Child Neurol., 42, 436, 10.1017/S0012162200000839 · DOI · Paper page
- Efron, 2020, Assessment and management of tic disorders and Tourette syndrome by Australian paediatricians, J Paediatr Child Health., 56, 136, 10.1111/jpc.14541 · DOI
- Bachmann, 2015, Trends in psychopharmacologic treatment of tic disorders in children and adolescents in Germany, Eur Child Adolesc Psychiatry., 24, 199, 10.1007/s00787-014-0563-6 · DOI
- Carulla-Roig, 2018, Pharmacoepidemiology of Tourette and Chronic Tic Disorders in Sweden 2005–2013, J Child Adolesc Psychopharmacol., 28, 637, 10.1089/cap.2017.0169 · DOI
- Hamamoto, 2019, Expert consensus on pharmacotherapy for tic disorders in Japan, Brain Dev., 41, 501, 10.1016/j.braindev.2019.02.003 · DOI
- Munce, 2017, Health and Community-Based Services for Individuals with Neurological Conditions, Can J Neurol Sci., 44, 670, 10.1017/cjn.2017.207 · DOI
- Wolicki, 2019, Children with Tourette Syndrome in the United States: Parent-Reported Diagnosis, Co-Occurring Disorders, Severity, and Influence of Activities on Tics, J Dev Behav Pediatr., 40, 407, 10.1097/DBP.0000000000000667 · DOI
- Rivera-Navarro, 2009, The diagnosis of Tourette's Syndrome: communication and impact, Clin Child Psychol Psychiatry., 14, 13, 10.1177/1359104508100127 · DOI
- Cuenca, 2015, Perceptions of treatment for tics among young people with Tourette syndrome and their parents: a mixed methods study, BMC Psychiatry., 15, 46, 10.1186/s12888-015-0430-0 · DOI
- Marcks, 2004, What do those who know, know? Investigating providers' knowledge about Tourette's Syndrome and its treatment, Cognit Behav Pract., 11, 298, 10.1016/S1077-7229(04)80044-0 · DOI
- Woods, 2007, Barriers to Dissemination: Exploring the Criticisms of Behavior Therapy for Tics, 14, 279, 10.1111/j.1468-2850.2007.00088.x · DOI · Paper page
- Kim, 2003, The American Academy of Child and Adolescent Psychiatry Task Force on, Workforce Needs. Child and adolescent psychiatry workforce: a critical shortage and national challenge, Academic Psychiatry., 27, 277, 10.1176/appi.ap.27.4.277 · DOI · Paper page
- Leckman, 1998, Course of tic severity in Tourette syndrome: the first two decades, Pediatrics., 102, 14, 10.1542/peds.102.1.14 · DOI · Paper page
- Rizzo, 2012, Long term clinical course of Tourette syndrome, Brain Dev., 34, 667, 10.1016/j.braindev.2011.11.006 · DOI
- Verdellen, European clinical guidelines for Tourette Syndrome and other tic disorders. Part III: behavioural and psychosocial interventions, Eur Child Adolesc Psychiatry., 20, 197, 10.1007/s00787-011-0167-3 · DOI · Paper page
- Steeves, 2012, Canadian guidelines for the evidence-based treatment of tic disorders: behavioural therapy, deep brain stimulation, and transcranial magnetic stimulation, Can J Psychiatry., 57, 144, 10.1177/070674371205700303 · DOI · Paper page
- Cath, 2011, European clinical guidelines for Tourette Syndrome and other tic disorders. Part I: assessment, Eur Child Adolesc Psychiatry., 20, 155, 10.1007/s00787-011-0164-6 · DOI · Paper page
- Conelea, Treating tourette together: an agenda for patient-centered research focused on comprehensive behavior therapy for tics, PsyArXiv [Preprint]., 10.31234/osf.io/qhb2z · DOI
- Olfson, 2011, Patterns and correlates of tic disorder diagnoses in privately and publicly insured youth, J Am Acad Child Adolesc Psychiatry., 50, 119, 10.1016/j.jaac.2010.11.009 · DOI
- Smith, 2017, Outpatient Treatment of Tic Disorders Among Children and Adults, Mov Disord Clin Pract., 4, 559, 10.1002/mdc3.12472 · DOI
- Himle, 2012, A randomized pilot trial comparing videoconference versus face-to-face delivery of behavior therapy for childhood tic disorders, Behav Res Ther., 50, 565, 10.1016/j.brat.2012.05.009 · DOI · Paper page
- Cothros, 2019, Prescriptions for alpha agonists and antipsychotics in children and youth with tic disorders: a pharmacoepidemiologic study, Tremor Other Hyperkinet Mov., 9, 10.5334/tohm.459 · DOI
- Farag, 2015, Serial pharmacological prescribing practices for tic management in Tourette syndrome, Hum Psychopharmacol Clin Exp., 30, 435, 10.1002/hup.2495 · DOI
- Rickards, 2012, Treatment practices in Tourette syndrome: the European perspective, Eur J Paediatr Neurol., 16, 361, 10.1016/j.ejpn.2011.12.001 · DOI
- Osland, 2018, Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders, Cochrane Database Syst Rev., 6, CD007990, 10.1002/14651858.CD007990.pub3 · DOI
- Desarkar, 2006, Sertraline caused tics in a child with obsessive-compulsive disorder, J Pediatr Neurol., 4, 283, 10.1055/s-0035-1557335 · DOI
- Abi-Jaoude, 2009, Tourette syndrome: a model of integration. Handbook of Integrative Clinical Psychology, Psychiatry and Behavioral Medicine: Perspectives, Practices and Research, 549
- Reeves, 2009, Multimodal treatments versus pharmacotherapy alone in children with psychiatric disorders: implications of access, effectiveness, and contextual treatment, Paediatr Drugs., 11, 165, 10.2165/00148581-200911030-00002 · DOI
- Ganos, 2016, Tics in the pediatric population: pragmatic management, Mov Disord Clin Pract., 1, 145, 10.1002/mdc3.12043 · DOI
Cited by
Andrén, P., Jakubovski, E., Murphy, T. L., Woitecki, K., Tarnok, Z., Zimmerman-Brenner, S., van de Griendt, J., Debes, N. M., Viefhaus, P., Robinson, S., et al. (2022) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-021-01845-z · Cited by 225
Metadata
- Authors
- Bhikram, T., Elmaghraby, R., Abi-Jaoude, E., & Sandor, P.
- Venue
- Frontiers in Psychiatry
- Publisher
- Frontiers Media SA
- Published
- 2021-02-26
- Volume
- 12
- ISSN
- 1664-0640
- Cited by
- 33
- References
- 5
- Funders
- Toronto General and Western Hospital Foundation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.